Beyond Traditional Diet Pills: Groundbreaking New Weight Loss Drug Is More Effective Than Current Treatments
“To our knowledge, this study represents the first clinical comparative effectiveness study of tirzepatide and semaglutide in adults with overweight or obesity,” researchers from the healthcare analytics firm Truveta wrote in their findings.Tirzepatide — marketed by Eli Lilly as Mounjaro and Zepbound — mimics the appetite-suppressing hormones GLP-1 and GIP. It’s been shown to spur greater, sustained weight loss than semaglutide.
The researchers analyzed the weight loss of more than 18,000 adults who took Mounjaro or Ozempic between May 2022 and September 2023. At the end of the first year, Mounjaro users had dropped 15.3% of their body weight, while Ozempic patients lost 8.3%.For the new study, researchers analyzed the weight loss of more than 18,000 adults who took Mounjaro or Ozempic between May 2022 and September 2023.than those with the chronic condition. Researchers are unsure why there was a difference but speculated it may be due to how these patients partake in other activities to lose weight.
Lifestyle Medicine Diabetes Fda Obesity Ozempic Research Study Says Weight Loss
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mounjaro leads to significantly more weight loss than Ozempic, study suggestsPeople taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.
Read more »
Ozempic, Mounjaro users turning to protein shakes to help beef up musclesOzempic and Mounjaro users are increasingly turning to protein drinks as a convenient way to supplement protein consumption and combat excess muscle loss.
Read more »
Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefitsThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »
Potential link between Ozempic, Wegovy and serious eye condition revealed in new studyPlastic surgeons warn of 'Ozempic face' crisis in Hollywood
Read more »
Ozempic, Wegovy may be linked to increased risk of condition that causes blindness, new study showsThe potential link to nonarteritic anterior ischemic optic neuropathy was discovered after analysis of nearly six years of data.
Read more »